| Researchers at the MIT-Harvard Center of Cancer Nanotechnology Excellence and the MIT Cancer Nanotechnology Platform Partnership are focused on the central goals of rapidly translating recent advances in nanotechnology for use in the diagnosis and treatment of cancer and the development of next generation nanomaterials. The image above is an electron micrograph of a suspended microchannel resonant (SMR) mass sensor under development by researchers at the MIT-Harvard CCNE/CNPP. This sensor is being developed for label-free detection of cancer biomarkers. The image shows a bottom view of the resonator that has been intentionally etched open to visualize the fluidic conduit inside. |
.png)
No hay comentarios:
Publicar un comentario